Goldman Sachs brings back coverage on Medtronic with a Neutral call
The bank reinstated research coverage on Medtronic plc, assigning a Neutral rating and setting a $84 price target, according to market reporting.
Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
The bank reinstated research coverage on Medtronic plc, assigning a Neutral rating and setting a $84 price target, according to market reporting.
THE APEX TIMES
Claude Fable 5, Anthropic’s newest “Mythos-class” model, is now offered on Amazon Bedrock for customers who want to run the model inside AWS environments, with safeguards and new tools aimed at longer, more autonomous workflows.
Even after strong fiscal Q2 results and an earnings beat, Broadcom shares slid nearly 14%. A key detail: AI-related bookings and customer partnerships are expanding faster than the market reaction suggests.
A fresh market call from 24/7 Wall St. puts Eli Lilly stock on track for a move higher over the next year, citing retatrutide Phase 3 attention, a recent earnings beat, and a rebound from earlier pricing and program-related worries.
The reported agreement gives Amneal a pathway to participate in the booming GLP-1 supply chain through manufacturing collaboration with Pfizer, while also positioning it for higher-value products like biosimilars. Pfizer’s involvement, however, is still light on specifics in public reporting.
Walmart is widening its retail media business through third-party advertising platform integrations, while also leaning further into delivery. The strategy could lift profit per customer, but investors are left with fewer clear outlines on timing and incremental margins.
Vertiv said it is deepening its work with NVIDIA on electrical infrastructure for AI-focused data centers, centered on an 800-volt direct current (DC) power architecture. The move comes as investors and customers weigh how quickly power systems scale with the pace of AI compute.
Tuesday’s drop in Apple (AAPL) stock was tied, in part, to broad weakness across markets, with additional commentary in market coverage pointing to spillover concerns from SpaceX’s anticipated move to public markets.
Shares of Nike (NKE) have fallen roughly 75% from their peak level, pushing the company’s dividend yield higher. Whether that makes the payout sustainable depends on progress in revenue growth, margins, and demand outlines that have been under pressure.